Navigation Links
Health-care eyes focus on San Francisco, war of the stents

The talk of the town (the town being San Francisco, which kicks of the JP Morgan Annual Healthcare Conference on Monday) will most likely be the news from Sunday and early Monday that the Johnson & Johnson acquisition of Guidant for $22 billion is once again no longer a done deal.

On Sunday, Boston Scientific stepped into the fray yet again with its determin......

Full article >>> use of wire mesh to hold open blood vessels and permit increased blood flow in patients who either have occluded or closed vessels (or have them clogged up). In the last few years, the stent business has had further impetus with the incorporation of drugs such as paclitaxel into the stents.

These drugs render the stents more slippery so as not to let particles stick or cling to them. This......

Full article >>> .

Fourteen of the 26 stocks covered in this analysis were above the Dow and the Nasdaq National Market. Twelve declined versus these indices. This means theres a bit of a mixed bag with the tendency to be slightly better on those that outperformed. Some of the best companies had truly great years (particularly Dade-Behring, the leader in performance, and Monsanto).

Abbott spin-of......

Full article >>> d technology news community distributed via the Web, the wireless Web and free daily e-mail newsletters.

The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made or opinions expressed......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/09/06


Related biology technology :

1. CIOs focus on the business case while facing authority erosion
2. Biotech officials praise focus of new venture fund
3. NameProtect sold, tech entrepreneur to focus on Jellyfish.com
4. Wisconsins role in health a focus of biotech event
5. Candidates sparring over jobs focuses debate on right issue
6. BarCampMilwaukee promises a tech-focused event
7. Angel fund to focus on women and minority businesses
8. Fusion 2006 symposium focuses on making IT work for businesses
9. Exec focuses on blogs as business tool
10. New UW position focusing on Internet security
11. State of biotech, medical device sector is focus of upcoming conference
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
(Date:2/23/2017)... ... 2017 , ... David Nolte, PhD accepted Purdue University’s 2016 ... Research Park of West Lafayette, Indiana. , The top commercialization award is ... success with, commercializing discoveries from Purdue research. “This award is truly an honor. ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
Breaking Biology News(10 mins):